Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Ready
Primary summary from verified readiness
- Confidence
- 80% · stale
- Computed at
- 2026-09-22T23:27:14.984527+00:00
- Claimed
- 80
- Reported
- 75
- Verified
- 68
- Gap
- +12
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Growing
Decision
What the current evidence supports
Human editorial judgment · 2026-09-22
Wait for stronger evidence
- Why
- Genuine first-in-class FDA authorization with strong peer-reviewed signal quality, but it is a diagnostic adjunct in very early US commercial rollout (3 patients, 9 centers as of Feb 2026) with a thin installed base — too early to treat as a dependable substrate
- Next
- Track DETECT enrollment and US real-world data through 2026-2027; revisit once multi-center US clinical-utility outcomes and stable reimbursement are demonstrated beyond the initial epilepsy-center rollout
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 6
- Tier 1
- 4
- Tier 2
- 1
- Tier 3
- 1
- Supports
- 4
- Contradicts
- 1
- Context
- 1
- Latest observed
- 2026-02-25
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Revision 2
- 2026-07-19 Reading moved from ready to ready.
- 2026-09-22 Reading moved from ready to ready.